Lollipops replace needles: new pain relief for kids after tonsil surgery
NCT ID NCT07646093
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special lollipop containing the painkiller diclofenac to help children aged 4 to 12 manage pain after having their tonsils removed. Fifty children received a weight-adjusted dose every 8 hours for the first day after surgery. The goal was to see if the lollipop reduced pain and was easy for kids to take.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
4 to 12 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged 4 to 12 years. * Scheduled for elective adenotonsillectomy under general anaesthesia. * American Society of Anesthesiologists (ASA) physical status I or II. * Ability to tolerate oral administration of the medicated lollipop after surgery. * Written informed consent obtained from a parent or legal guardian. Exclusion Criteria: * Known hypersensitivity or contraindication to diclofenac or other non-steroidal anti-inflammatory drugs. * History of asthma precipitated by NSAIDs. * Active gastrointestinal ulcer disease or gastrointestinal bleeding. * Significant hepatic, renal, cardiovascular, or coagulation disorders. * Severe developmental delay or neurological conditions preventing reliable pain assessment. * Requirement for postoperative intensive care admission. * Refusal of participation by the patient or parent/legal guardian.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Adenoid hypertrophy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario de Caracas
Caracas, Miranda, 1040, Venezuela
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Protein periostin probed as possible driver of childhood adenoid overgrowth
- Can adding tramadol to spinal anesthesia extend pain relief after leg surgery?
- Can a local anesthetic injection curb Kids' pain after tonsil removal?
- Can a new Non-Opioid pill cut painkiller needs after throat surgery?
- Could untreated enlarged adenoids bend the nasal septum in teens?
- Can a storybook calm kids before surgery?